BNP Paribas Discount Zert MHL 30..../ DE000PC2LN56 /
| 2024-05-13 8:54:04 AM | Chg.-0.52 | Bid10:00:38 PM | Ask10:00:38 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 381.04EUR | -0.14% | - Bid Size: - |
- Ask Size: - |
S+P GLOBAL INC. ... | - - | 2024-12-30 | Call |
GlobeNewswire
10:44 PM
Chocxo Dark Milk Chocolate Snaps Named a Winner in Good Housekeeping’s 2024 Best Snack Awards
GlobeNewswire
10:30 PM
Farmers & Merchants Bancorp (FMCB) ranked #6 on Forbes Magazine’s List of “America’s Best Banks” for...
GlobeNewswire
10:30 PM
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire
10:30 PM
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
GlobeNewswire
10:30 PM
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire
10:30 PM
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticip...
GlobeNewswire
10:16 PM
Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
10:15 PM
Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcas...
GlobeNewswire
10:14 PM
Lottery.com Announces Appointment of New Strategic Financial Adviser to Accelerate and Expand Global...
GlobeNewswire
10:05 PM
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Financial Results
GlobeNewswire
10:05 PM
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
GlobeNewswire
10:05 PM
Banzai Continues Strong Organic Growth with the Addition of Over 230 Customers in April
GlobeNewswire
10:02 PM
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
GlobeNewswire
10:01 PM
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire
10:01 PM
Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
10:01 PM
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
